Systems biology represents a groundbreaking approach to overcome the current limitations of disease complexity and drug discovery. The development of systems biology will lay the foundation for a prospective medicine that will be predictive, personalized, preventive and participatory (4P-Medicine). It will enhance patient care and help controlling escalating health expenditure.Suivre @EISBM_EU
EISBM aims at fostering the development of systems approaches to fundamental biological questions and their application to important medical problems. EISBM will base its activities on an international network of academic centres, and also work in partnership with industry to boost the transfer of results to routine patient care, by:
Founded by Dr. Charles Auffray and his cross-disciplinary team, with the support of the Lyonbiopôle world-class competitiveness cluster and Université Claude Bernard - Lyon 1, EISBM is headquartered in Lyon-Gerland (France). It benefits from the valuable competences of its academic and industrial partners within the Lyon and Grenoble international competitive clusters in the fields of biological, medical and technological research.
Building open global partnership models, EISBM is working in close relation with major European universities and a network of systems biology and medicine centres worldwide.
EISBM is the European cornerstone of the Systemoscope Consortium, dedicated to systems biology and medicine and founded in 2002 by Dr Charles Auffray, Prof. Zhu Chen (Center for Systems Biomedicine – Shanghai, China) and Prof. Leroy Hood (Institute for Systems Biology – Seattle, USA).
Join the EISBM Team: Job opportunities.